Connective tissue disorders in COVID-19: Reply to "People with a connective tissue disorder may be especially vulnerable to the endothelial damage that characterizes long COVID due to the fragility of their vasculature and slow wound healing"
- PMID: 38532037
- DOI: 10.1007/s10456-024-09915-x
Connective tissue disorders in COVID-19: Reply to "People with a connective tissue disorder may be especially vulnerable to the endothelial damage that characterizes long COVID due to the fragility of their vasculature and slow wound healing"
Abstract
Connective tissue serves as a framework for other tissues and organs, supporting their functions, shielding them from harmful factors, and aiding repair. In COVID-19, damaged endothelial cells (ECs), increased endothelial permeability, and thrombi contribute to the connective tissue disorders. Even post-recovery, the damage to ECs and connective tissues persists, resulting in long COVID. Individuals with connective tissue disorders are prone to developing severe COVID-19 and experiencing long COVID symptoms. It is advised that these patients receive at least three vaccine doses, undergo early prophylactic antithrombotic therapy during acute COVID-19, and maintain prophylactic anticoagulant treatment in cases of long COVID.
© 2024. The Author(s), under exclusive licence to Springer Nature B.V.
Similar articles
-
People with a connective tissue disorder may be especially vulnerable to the endothelial damage that characterizes long COVID due to the fragility of their vasculature and slow wound healing.Angiogenesis. 2024 May;27(2):123-124. doi: 10.1007/s10456-024-09908-w. Epub 2024 Feb 6. Angiogenesis. 2024. PMID: 38319491
-
Damage to endothelial barriers and its contribution to long COVID.Angiogenesis. 2024 Feb;27(1):5-22. doi: 10.1007/s10456-023-09878-5. Epub 2023 Apr 27. Angiogenesis. 2024. PMID: 37103631 Free PMC article. Review.
-
Long COVID: The Nature of Thrombotic Sequelae Determines the Necessity of Early Anticoagulation.Front Cell Infect Microbiol. 2022 Apr 5;12:861703. doi: 10.3389/fcimb.2022.861703. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35449732 Free PMC article. Review.
-
Connective tissue matrices from placental disc for wound healing: mini-review.Biotechnol Lett. 2023 Aug;45(8):921-929. doi: 10.1007/s10529-023-03403-w. Epub 2023 Jun 8. Biotechnol Lett. 2023. PMID: 37289347 Review.
-
SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: Consequences of capillary transit-time changes, tissue hypoxia and inflammation.Physiol Rep. 2021 Feb;9(3):e14726. doi: 10.14814/phy2.14726. Physiol Rep. 2021. PMID: 33523608 Free PMC article. Review.
References
-
- Davis HE, McCorkell L, Vogel JM, Topol EJ (2023) Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 21(3):133–146. https://doi.org/10.1038/s41579-022-00846-2 - DOI - PubMed - PMC
-
- Hidalgo A, Libby P, Soehnlein O, Aramburu IV, Papayannopoulos V, Silvestre-Roig C (2022) Neutrophil extracellular traps: from physiology to pathology. Cardiovasc Res 118(13):2737–2753. https://doi.org/10.1093/cvr/cvab329 - DOI - PubMed
-
- Cheng Y, Lin CH, Chen JY, Li CH, Liu YT, Chen BC (2016) Induction of connective tissue growth factor expression by hypoxia in human lung fibroblasts via the MEKK1/MEK1/ERK1/GLI-1/GLI-2 and AP-1 pathways. PLoS ONE 11(8):e0160593. https://doi.org/10.1371/journal.pone.0160593 - DOI - PubMed - PMC
-
- Awosanya OD, Dadwal UC, Imel EA, Yu Q, Kacena MA (2022) The impacts of COVID-19 on musculoskeletal health. Curr Osteoporos Rep 20(4):213–225. https://doi.org/10.1007/s11914-022-00734-x - DOI - PubMed - PMC
-
- Zhao M, Wang L, Wang M, Zhou S, Lu Y, Cui H, Racanelli AC, Zhang L, Ye T, Ding B, Zhang B, Yang J, Yao Y (2022) Targeting fibrosis: mechanisms and clinical trials. Signal Transduct Target Ther 7(1):206. https://doi.org/10.1038/s41392-022-01070-3 - DOI - PubMed - PMC
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical